chondroitin and Postoperative-Complications

chondroitin has been researched along with Postoperative-Complications* in 24 studies

Reviews

3 review(s) available for chondroitin and Postoperative-Complications

ArticleYear
Ophthalmic viscosurgical devices.
    Current opinion in ophthalmology, 2008, Volume: 19, Issue:1

    The indications for ophthalmic viscosurgical devices have expanded with the introduction of newly developed ophthalmic viscosurgical devices. The characteristics of different ophthalmic viscosurgical devices and their specific uses in anterior segment surgery and possible problems are discussed.. Ophthalmic viscosurgical devices were first introduced to maintain space in the eye during the implantation of intraocular lenses. With the development of different types of ophthalmic viscosurgical devices, additional indications have been discussed. To protect the corneal endothelium, the ability of ophthalmic viscosurgical devices to be retained during phacoemulsification was compared. To enlarge and stabilize the size of the pupil, specific ophthalmic viscosurgical devices are used in patients with small pupils or intraoperative floppy iris syndrome. On the other hand, complications associated with the use of ophthalmic viscosurgical devices and their prevention have been discussed. Postoperative elevations of intraocular pressure have been reported and complete removal of the ophthalmic viscosurgical device at the end of surgery is the key factor to avoiding these elevations. Wound burns during phacoemulsification may occur and creating a fluid space around the phacoemulsification tip is necessary to avoid them.. The rheologic characteristics of the different types of ophthalmic viscosurgical device should be considered, and the appropriate use of ophthalmic viscosurgical devices in specific cases would improve the surgical outcomes.

    Topics: Animals; Chondroitin; Chondroitin Sulfates; Drug Combinations; Humans; Hyaluronic Acid; Lens Implantation, Intraocular; Phacoemulsification; Postoperative Complications; Prosthesis Design; Viscosity

2008
Viscoelastic-related glaucomas.
    Seminars in ophthalmology, 1994, Volume: 9, Issue:4

    The routine surgical use of viscoelastic substances has revolutionized many anterior segment procedures. All of the currently available agents may be responsible for causing or exacerbating a transient, but occasionally significant, postoperative IOP elevation. In spite of differences in physical properties such as molecular weight, concentration, and viscosity, none of the various viscoelastics has consistently shown a decreased likelihood of producing ocular hypertension. Moreover, any newly introduced product must be evaluated carefully for this potential complication. Lavage of viscomaterial from the anterior chamber and administration of ocular antihypertensives may be helpful in averting or controlling the increased IOP. The surgeon should be cognizant of any pre-existing optic nerve damage and adjust the aggressiveness of postoperative glaucoma therapy accordingly. In the future, the development of new substances or simultaneous use of degrading enzymes may reduce or eliminate the incidence of viscoelastic-induced ocular hypertension.

    Topics: Animals; Anterior Eye Segment; Chondroitin; Glaucoma; Humans; Hyaluronic Acid; Intraocular Pressure; Ocular Hypertension; Postoperative Complications

1994
[ON POSTOPERATIVE ADHESIONS IN GYNECOLOGY AND OBSTETRICS].
    [Sanfujinka chiryo] Obstetrical and gynecological therapy, 1964, Volume: 9

    Topics: Animals; Chondroitin; Deoxyribonuclease I; Dexamethasone; Drug Therapy; Female; Gynecology; Humans; Hysterectomy; Lagomorpha; Obstetrics; Pathology; Postoperative Complications; Povidone; Pregnancy; Rabbits; Research; Streptodornase and Streptokinase; Streptokinase; Streptomycin; Surgical Procedures, Operative; Tissue Adhesions; Trypsin

1964

Trials

5 trial(s) available for chondroitin and Postoperative-Complications

ArticleYear
Effect of antiglaucoma agents on postoperative intraocular pressure after cataract surgery with Viscoat.
    Journal of cataract and refractive surgery, 2007, Volume: 33, Issue:11

    To compare the effectiveness of brinzolamide 1%, brimonidine 0.2%, acetazolamide 250 mg, intracameral acetylcholine, and timolol 0.5% in preventing intraocular pressure (IOP) peaks during the early period after phacoemulsification in which sodium chondroitin sulfate 4%-sodium hyaluronate 3% (Viscoat) was used as the ophthalmic viscosurgical device (OVD).. Department of Ophthalmology, Baskent University Medical Faculty, Ankara, Turkey.. This prospective randomized study comprised 185 eyes of 185 patients with uncomplicated cataract scheduled for phacoemulsification using Viscoat as the OVD. Patients were randomly assigned to 1 of 6 groups: postoperative application of topical brinzolamide 1%, brimonidine 0.2%, oral acetazolamide 250 mg, intracameral acetylcholine, timolol 0.5%, or no ocular hypotensive agent (control group). The IOP was measured at baseline (preoperatively) as well as 6 hours, 20 to 24 hours, and 1 week after surgery.. The mean preoperative IOP values were not significantly different between the groups. Six hours and 20 to 24 hours postoperatively, the mean IOP was significantly lower in all groups receiving an ocular hypotensive agent than in the control group (P<.01). Six hours after surgery, the mean IOP significantly increased in all groups but was higher in the control group. At 20 to 24 hours, the mean IOP decreased significantly in all ocular hypotensive agent groups but remained significantly high in the control group. One week after surgery, there were no significant differences between the groups.. Brinzolamide, brimonidine, acetazolamide, intracameral acetylcholine, and timolol had similar effects in reducing IOP increases after phacoemulsification performed using Viscoat.

    Topics: Acetazolamide; Acetylcholine; Administration, Topical; Aged; Aged, 80 and over; Antihypertensive Agents; Brimonidine Tartrate; Chondroitin; Chondroitin Sulfates; Double-Blind Method; Drug Combinations; Female; Humans; Hyaluronic Acid; Intraocular Pressure; Lens Implantation, Intraocular; Male; Middle Aged; Ocular Hypertension; Phacoemulsification; Postoperative Complications; Prospective Studies; Quinoxalines; Sulfonamides; Thiazines; Timolol; Tonometry, Ocular

2007
Intraocular pressure rise after small incision cataract surgery: a randomised intraindividual comparison of two dispersive viscoelastic agents.
    The British journal of ophthalmology, 2001, Volume: 85, Issue:2

    To evaluate the effects of the dispersive viscoelastic agents Ocucoat (hydroxypropyl methylcellulose 2%) and Viscoat (sodium chondroitin sulphate 4%-sodium hyaluronate 3%) on postoperative intraocular pressure (IOP) after bilateral small incision cataract surgery.. This prospective, randomised study comprised 80 eyes of 40 consecutive patients with age related cataract in both eyes scheduled for bilateral small incision cataract surgery. The patients were randomly assigned to receive Ocucoat or Viscoat during cataract surgery of the first eye. The second eye was operated later and received the other viscoelastic agent. Cataract surgery was performed with a temporal 3.2 mm sutureless posterior limbal incision, phacoemulsification, and implantation of a foldable silicone intraocular lens. The IOP was measured preoperatively as well as 6 hours, 20-24 hours, and 1 week postoperatively.. At 6 hours after surgery the mean IOP increased by 4.6 (SD 5.1) mm Hg in the Ocucoat group (p<0.001) and by 8.6 (8.1) mm Hg in the Viscoat group (p<0.001). The increase was significantly higher in the Viscoat group than in the Ocucoat group (p=0.004). Intraocular pressure spikes of 30 mm Hg or more occurred in two eyes in the Ocucoat and in nine eyes in the Viscoat group (p=0.023); 20-24 hours and 1 week postoperatively the mean IOP was not statistically different.. These findings indicate that Viscoat causes a significantly higher IOP increase and significantly more IOP spikes than Ocucoat in the early period after small incision cataract surgery.

    Topics: Aged; Aged, 80 and over; Chondroitin; Chondroitin Sulfates; Double-Blind Method; Drug Combinations; Female; Humans; Hyaluronic Acid; Hypromellose Derivatives; Intraoperative Care; Male; Methylcellulose; Middle Aged; Ocular Hypertension; Phacoemulsification; Postoperative Complications; Postoperative Period; Prospective Studies; Viscosity

2001
Postoperative intraocular pressure rises: a comparison of Healon, Amvisc, and Viscoat.
    Journal of cataract and refractive surgery, 1989, Volume: 15, Issue:4

    A prospective randomized study was performed involving 200 patients divided into four groups: (1) Healon aspirated, (2) Amvisc aspirated, (3) Viscoat aspirated, and (4) Viscoat not aspirated. Postoperative intraocular pressures were measured at 4, 8, and 24 hours, two to three days, and one month. Significant differences between the groups were noted at four and eight hours; however, by 24 hours there were no significant differences. There were also no significant differences at two to three days and one month postoperatively. In this study, the Viscoat-not-aspirated group had the highest intraocular pressures followed, in decreasing order, by the Viscoat aspirated group, the Amvisc aspirated group, and the Healon aspirated group. From this study, I have concluded that Viscoat should be aspirated at the end of surgery to avoid postoperative intraocular pressure rises. Healon appears to be associated with lower intraocular pressures than the other two agents at four and eight hours postoperatively.

    Topics: Cataract Extraction; Chondroitin; Chondroitin Sulfates; Humans; Hyaluronic Acid; Intraocular Pressure; Lenses, Intraocular; Postoperative Complications; Prospective Studies; Random Allocation; Time Factors; Tonometry, Ocular

1989
A randomized study of a semisynthetic heparin analogue and heparin in prophylaxis of deep vein thrombosis.
    The British journal of surgery, 1984, Volume: 71, Issue:11

    The prophylactic effect of a semisynthetic heparin analogue (SSHA) on deep vein thrombosis was investigated in a prospective double-blind multicentre trial. 440 major general surgical and gynaecological patients were randomized to one of three treatment groups: 50 mg SSHA, 37.5 mg SSHA and 5000 units sodium heparin subcutaneously 12-hourly. Deep venous thrombosis (DVT) was diagnosed with the fibrinogen uptake test and verified with phlebography. Bleeding complications and other side-effects were carefully monitored. There were no significant differences between the three treatment groups of patients in age, sex, type of operation or risk factors. A DVT was diagnosed in 16 patients (12 per cent) in the SSHA 50 mg group, in 21 patients (15 per cent) in the SSHA 37.5 mg group and 21 patients (14 per cent) in the heparin-treated group. No significant differences were found in the number of patients who bled unexpectedly in the postoperative period, required transfusion or developed wound haematomas. Blood loss at operation was similar in all three groups. Three pulmonary emboli were diagnosed by pulmonary scintigraphy, one in each group.

    Topics: Adult; Aged; Anticoagulants; Chondroitin; Chondroitin Sulfates; Double-Blind Method; Female; Hemorrhage; Heparin; Humans; Intraoperative Complications; Male; Middle Aged; Postoperative Complications; Prospective Studies; Random Allocation; Risk; Surgical Procedures, Operative; Thrombophlebitis

1984
Effects of heparin and a semi-synthetic heparin analogue on platelet aggregation, lipoprotein lipase and other laboratory tests in surgical patients.
    Thrombosis research, 1983, Jun-01, Volume: 30, Issue:5

    Platelet aggregation, lipoprotein lipase activity, coagulation parameters and routine blood chemistry were measured in a randomised study of 21 surgical patients before, immediately after and 3 months after operation. Sodium heparin 5000 IU was given subcutaneously to 11 patients every 12 hours for 7 days, the first injection 2 hours preoperatively; 10 patients received a semi-synthetic heparin analogue (SSHA 75 mg) in the same manner. The groups were sex and age matched. No conclusive changes were found in platelet aggregation. The increase in lipoprotein lipase activity in SSHA patients 2 hours after injection was significantly greater than in heparin patients. Neither of the two drugs induced significant changes in coagulation parameters or routine blood chemistry. The results indicate a difference in the effect on lipoprotein lipase release between heparin and SSHA at the used dosage schedules.

    Topics: Aged; Anticoagulants; Blood Coagulation Tests; Chondroitin; Chondroitin Sulfates; Female; Heparin; Humans; Lipoprotein Lipase; Male; Platelet Aggregation; Postoperative Complications; Thrombophlebitis

1983

Other Studies

16 other study(ies) available for chondroitin and Postoperative-Complications

ArticleYear
Identification of unknown intraocular material after cataract surgery: evaluation of a potential cause of toxic anterior segment syndrome.
    Journal of cataract and refractive surgery, 2008, Volume: 34, Issue:3

    To describe and identify unknown opaque material between the optic of an AR40 intraocular lens (IOL) injected with the Emerald Series implantation system (both AMO, Inc.) and the posterior capsule at the conclusion of routine phacoemulsification to prevent an outbreak of toxic anterior segment syndrome (TASS).. Ambulatory care center operating room, University of North Carolina Hospitals and Department of Ophthalmology, University of North Carolina School of Medicine at Chapel Hill, Chapel Hill, North Carolina, USA.. After coaxial phacoemulsification in multiple patients, opaque material was present between the optic of a posterior chamber IOL and the posterior capsule. Although there was no TASS, the material was removed from 2 eyes and analyzed with scanning electron microscopy (SEM) and x-ray microanalysis (XRM). Similarly, crystalline lens, Klenzyme (Steris Corp.), Viscoat (sodium hyaluronate 3.0%-chondroitin sulfate 4.0%), and Provisc (sodium hyaluronate 1.0%) were analyzed.. On SEM, the material had an irregular undulating surface similar to that of Provisc. Viscoat and the crystalline lens had smoother surfaces. On XRM, the material contained sodium, chlorine, and calcium, like Viscoat and Provisc, and phosphorous and sulfur, like Viscoat. The material also contained silicone, magnesium, aluminum, titanium, iron, and zinc. Klenzyme had smaller peaks of sodium, chlorine, and calcium and a higher carbon background than the unknown material.. The material was likely ophthalmic viscosurgical device that was chemically and structurally altered by the cleaning and sterilization process. The silicone and metallic elements were probably from the Emerald Series implantation system as the disposable cartridge is coated with silicone and the reusable injector is metal.

    Topics: Anterior Eye Segment; Chondroitin; Chondroitin Sulfates; Drug Combinations; Electron Probe Microanalysis; Foreign-Body Reaction; Humans; Hyaluronic Acid; Lens Capsule, Crystalline; Lens Implantation, Intraocular; Microscopy, Electron, Scanning; Phacoemulsification; Postoperative Complications; Syndrome; Uveitis, Anterior

2008
Natural course of intraocular pressure after cataract surgery with sodium chondroitin sulfate 4%-sodium hyaluronate 3% (Viscoat).
    Ophthalmology, 2005, Volume: 112, Issue:10

    To investigate the natural course of intraocular pressure (IOP) and its peak after small-incision cataract surgery with chondroitin sulfate 4%-sodium hyaluronate 3% (Viscoat, Alcon Laboratories, Inc., Fort Worth, TX).. Observational case series.. This prospective study comprised 40 eyes of 40 consecutive cataract patients scheduled for small-incision cataract surgery.. Cataract surgery was performed with sodium chondroitin sulfate 4%-sodium hyaluronate 3% as the ophthalmic viscosurgical device, which was removed as completely as possible from the eye at the end of surgery. The IOP was measured preoperatively and 30 minutes; 1, 2, 3, 4, 6, 8, and 20 to 24 hours; and 1 week postoperatively.. Postoperative IOP increase.. The mean IOP increased significantly at all observation times during the first 20 to 24 hours, with a peak increase of 13.4+/-9.4 mmHg after 1 hour (P<0.05). In all, 28 eyes (70%) had an IOP spike to 30 mmHg or higher. Sixty-eight percent of these spikes occurred at 30 minutes as well as at 1 hour and 2 hours postoperatively. At 20 to 24 hours, no eye had an IOP spike to 30 mmHg or higher.. Significant IOP increases were found during the first 24 hours, peaking at 1 hour after surgery. With a single postoperative IOP measurement, between 30 minutes and 2 hours after surgery, two thirds of these IOP spikes could be detected. To detect all IOP spikes, a second measurement between 4 and 6 hours after surgery would be necessary.

    Topics: Aged; Chondroitin; Chondroitin Sulfates; Drug Combinations; Female; Humans; Hyaluronic Acid; Intraocular Pressure; Lens Implantation, Intraocular; Male; Ocular Hypertension; Phacoemulsification; Postoperative Complications; Postoperative Period; Prospective Studies; Time Factors; Tonometry, Ocular

2005
Removal times for a dispersive and a cohesive ophthalmic viscosurgical device correlated with intraocular lens material.
    Journal of cataract and refractive surgery, 2004, Volume: 30, Issue:11

    To investigate the removal times of ophthalmic viscosurgical devices (OVDs) with different intraocular lens (IOL) designs and materials.. Center for Research on Ocular Therapeutics and Biodevices, Department of Ophthalmology, Storm Eye Institute, Medical University of South Carolina, Charleston, South Carolina, USA, and Heidelberg IOL & Refractive Surgery Research Group, Department of Ophthalmology, Ruprecht-Karls-University of Heidelberg, Heidelberg, Germany.. In a standardized laboratory setup, the Miyake-Apple posterior view video technique was used to evaluate OVD removal from capsular bags in human autopsy eyes implanted with poly(methyl methacrylate) (PMMA), silicone, and acrylic IOLs. The cohesive OVD ProVisc (sodium hyaluronate 1.0%) and the dispersive OVD Viscoat (sodium hyaluronate 3.0% and chondroitin sulfate 4.0%) were stained with fluorescein for better visualization. The open-sky preparation and an Alcon Series 20000 Legacy phaco machine with a flow rate of 25 mL/min and a vacuum setting of +500 mm Hg (maximum irrigation/aspiration) were used. The time needed for complete removal of the cohesive and dispersive OVDs with each IOL type was measured and analyzed statistically.. The mean removal times for both OVDs were as follows: Alcon MZ60BD PMMA IOL-25.0 seconds +/- 3.7 (SD) (Viscoat), 15.9 +/- 6.9 seconds (ProVisc); Alcon AcrySof MA60BM IOL-35.5 +/- 10.0 seconds (Viscoat), 25.6 +/- 4.7 seconds (ProVisc); Chiron/Bausch & Lomb C1043 silicone IOL-46.5 +/- 10.5 seconds (Viscoat), 17.3 +/- 2.1 seconds (ProVisc); AMO SI-30 silicone IOL-33.5 +/- 3.1 seconds (Viscoat), 15.3 +/- 6.3 seconds (ProVisc); and Pharmacia 912 silicone IOL-18.3 +/- 5.8 seconds (Viscoat), 19.8 +/- 4.3 seconds (ProVisc).. Differences in OVD removal times were detected. The removal time for the cohesive OVD correlated with the IOL material. Overall, the time needed for complete removal was significantly longer for the dispersive OVD than for the cohesive OVD.

    Topics: Acrylic Resins; Biocompatible Materials; Chondroitin; Chondroitin Sulfates; Drainage; Drug Combinations; Humans; Hyaluronic Acid; Intraoperative Complications; Lens Implantation, Intraocular; Lenses, Intraocular; Phacoemulsification; Polymethyl Methacrylate; Postoperative Complications; Silicone Elastomers; Time Factors

2004
Opacification of piggyback IOLs associated with an amorphous material attached to interlenticular surfaces.
    Journal of cataract and refractive surgery, 2000, Volume: 26, Issue:11

    To report the pathological and ultrastructural features and interval surgical management of an atypical case of opacification between piggyback intraocular lenses (IOLs).. Center for Research on Ocular Therapeutics and Biodevices, Storm Eye Institute, Medical University of South Carolina, Charleston, South Carolina, and Nature Coast EyeCare Institute and Surgery Center, Perry, Florida, USA.. Opacification between 2 acrylic piggyback lenses was observed 16 months after implantation, with decreased best corrected visual acuity and a hyperopic shift. Elschnig pearls were observed in the peripheral interface between the lenses, and the central interface was occupied by an amorphous material. The pearls were surgically aspirated, but attempts to remove the central material were unsuccessful. The lenses were explanted and sent to the laboratory. Staining with hematoxylin and eosin (H&E), examination under a light microscope, and scanning electron microscopic analysis were performed.. The surfaces of the anterior IOL were relatively clear. The amorphous material, mostly attached to the center of the anterior surface of the posterior IOL, was homogeneously stained with H&E. No cell nucleus was observed in this region. Scanning electron microscopy showed that the IOL edge presented a smooth, regular surface relatively free of deposits. The most central region was covered by an irregular layer of an amorphous compact material with some cracks, fissures, or both on its surface.. Although the exact composition of the material between the lenses could not be established, hypotheses were advanced to understand the pathological mechanism associated with this condition. This case is different from those in previous reports of opacification composed of cortex and cells between piggyback IOLs.

    Topics: Acrylates; Adhesiveness; Biocompatible Materials; Chondroitin; Chondroitin Sulfates; Device Removal; Drug Combinations; Female; Humans; Hyaluronic Acid; Lenses, Intraocular; Microscopy, Electron, Scanning; Middle Aged; Postoperative Complications; Prosthesis Failure; Reoperation

2000
Removal of viscoelastics.
    Journal of cataract and refractive surgery, 1992, Volume: 18, Issue:4

    Topics: Cataract Extraction; Chondroitin; Chondroitin Sulfates; Drug Combinations; Humans; Hyaluronic Acid; Intraocular Pressure; Ocular Hypertension; Postoperative Complications

1992
Effects of Healon vs. Viscoat on endothelial cell count and morphology after phacoemulsification and posterior chamber lens implantation.
    Canadian journal of ophthalmology. Journal canadien d'ophtalmologie, 1992, Volume: 27, Issue:3

    The endothelial cell count and several morphologic characteristics of the cells were examined before and after surgery in 56 consecutive patients (60 eyes) who underwent phacoemulsification and implantation of a posterior chamber intraocular lens with either Healon (30 eyes) or Viscoat (30 eyes) as the viscoelastic material. In all cases the technique was the same, including removal of the viscoelastic from the anterior chamber at the end of the operation. The mean cell loss was greater in the Viscoat group than in the Healon group (9.27% +/- 2.52% vs. 2.71% +/- 2.53%), but not significantly so. There was a significantly greater reduction in polymegathism in the Healon group than in the Viscoat group (p less than 0.05). Although the results suggest that Healon has a greater protective effect on the corneal endothelium than Viscoat, the greater effort needed to remove Viscoat from the anterior chamber may have adversely affected the endothelium. Further studies in which Viscoat is left in the eye are warranted.

    Topics: Aged; Cataract Extraction; Cell Count; Chondroitin; Chondroitin Sulfates; Drug Combinations; Endothelium, Corneal; Female; Humans; Hyaluronic Acid; Lenses, Intraocular; Male; Postoperative Complications

1992
Chondroitin sulphate. A new intraperitoneal treatment for postoperative adhesion prevention in the rabbit.
    The Journal of reproductive medicine, 1987, Volume: 32, Issue:11

    A study was designed to test chondroitin sulphate and other high-molecular-weight solutions, using the rabbit uterus as the surgical model, in the prevention of postoperative adhesions. Eighty-five mature white female New Zealand rabbits underwent surgical injury of each uterine horn, with surgical repair of the left horn only in all animals using 9-0 nylon. The rabbits were randomly divided into five groups: groups A, B and C received 25 mL of chondroitin sulphate, sodium carboxymethylcellulose or 32% dextran 70, respectively. The remaining two groups received either 50 mL of normal saline (D) or no solution (E). Postoperatively the animals were killed, and the adhesions were carefully scored. The results clearly demonstrated the superiority of chondroitin sulphate as an intraperitoneal treatment for the prevention of postoperative adhesions (P less than .001 vs. carboxymethyl cellulose, dextran, saline and control).

    Topics: Animals; Carboxymethylcellulose Sodium; Chondroitin; Chondroitin Sulfates; Dextrans; Female; Injections, Intraperitoneal; Methylcellulose; Peritoneum; Postoperative Complications; Rabbits; Tissue Adhesions; Uterine Diseases

1987
Calcific band keratopathy after intraocular chondroitin sulfate.
    Archives of ophthalmology (Chicago, Ill. : 1960), 1987, Volume: 105, Issue:9

    A patient developed an acute onset of pseudophakic bullous keratopathy and a diffuse, gray, subepithelial corneal deposit ten days following surgery during which sodium chondroitin sulfate was used. The deposit, identified histologically as calcium, was noted throughout Bowman's layer. The absence of chronic pathologic features in the posterior cornea eliminated Fuchs' endothelial dystrophy as the cause of the acute corneal decompensation. This histopathologic confirmation of calcium deposition with one formulation of chondroitin sulfate, combined with similar conclusions from previous case reports, stimulated the reformulation of the product, which has been shown to be useful in clinical practice.

    Topics: Aged; Calcinosis; Cataract Extraction; Chondroitin; Cornea; Corneal Diseases; Corneal Opacity; Corneal Transplantation; Female; Humans; Lenses, Intraocular; Postoperative Complications

1987
Corneal subepithelial deposits after use of sodium chondroitin.
    American journal of ophthalmology, 1986, Aug-15, Volume: 102, Issue:2

    Topics: Calcinosis; Cataract Extraction; Chondroitin; Cornea; Corneal Diseases; Epithelium; Humans; Lenses, Intraocular; Postoperative Complications

1986
Comparison of the effects of viscoat and healon on postoperative intraocular pressure.
    American journal of ophthalmology, 1986, Sep-15, Volume: 102, Issue:3

    Topics: Chondroitin; Chondroitin Sulfates; Drug Combinations; Humans; Hyaluronic Acid; Intraocular Pressure; Postoperative Complications

1986
Lung transplantation: better survival results after graft pretreatment with concanavalin A or chondroitin sulfate.
    The Annals of thoracic surgery, 1980, Volume: 29, Issue:3

    Pretreatment of the lung graft with concanavalin A (Con A) or chondroitin sulfate (CIS) was used to modify the lung allograft response after transplantation into moderately immunosuppressed (low doses of azathioprine and prednisone) recipients. Significant (p less than 0.05) prolongation of survival was observed after graft pretreatment. Pneumonia and rejection were the most frequent causes of death for all groups of dogs. However, only 3 out of 6 animals from each of the groups with pretreated grafts died of pneumonia or rejection, whereas 5 of the 6 animals in the control group died of these causes. Furthermore, when rejection occurred in the dogs with lung grafts pretreated with Con A or CIS, it was considerably delayed compared with the controls. Partial pressure of arterial oxygen, chest roentgenograms, and lung histology were good indicators of lung viability after transplantation.

    Topics: Animals; Chondroitin; Chondroitin Sulfates; Concanavalin A; Dogs; Female; Graft Rejection; Lung; Lung Transplantation; Male; Pneumonia; Postoperative Complications; Radiography; Transplantation, Homologous

1980
[Prevention of postoperative peritoneal adhesions].
    Die Medizinische Welt, 1973, Aug-10, Volume: 24, Issue:31

    Topics: Adult; Aged; Animals; Aprotinin; Chondroitin; Dexamethasone; Female; Humans; Intestine, Small; Laparotomy; Male; Mesentery; Middle Aged; Omentum; Postoperative Complications; Rats; Tissue Adhesions

1973
[Prevention of intestinal adhesion and ileus after laparotomy].
    Sanfujinka no jissai. Practice of gynecology and obstetrics, 1971, Volume: 20, Issue:5

    Topics: Abdomen; Chondroitin; Female; Humans; Intestinal Diseases; Intestinal Obstruction; Japan; Postoperative Complications; Povidone; Prednisolone; Tissue Adhesions

1971
[Problems of postoperative intestinal adhesion].
    Geka chiryo. Surgical therapy, 1971, Volume: 24, Issue:4

    Topics: Adolescent; Adult; Age Factors; Chondroitin; Female; Humans; Intestinal Diseases; Intestinal Obstruction; Male; Methods; Middle Aged; Postoperative Complications; Psychophysiologic Disorders; Sex Factors; Tissue Adhesions

1971
[Clinical evaluation of a complex ophthalmic solution containing colistin, chloramphenicol and chondroitin sulfate, with special reference to the latest bacteriological findings of suppurative lesions of the eye].
    Nihon ganka kiyo, 1969, Volume: 20, Issue:7

    Topics: Abscess; Adult; Aged; Chloramphenicol; Chondroitin; Colistin; Eye Diseases; Female; Humans; Male; Middle Aged; Ophthalmic Solutions; Postoperative Complications

1969
[PREVENTION OF ADHESION FOLLOWING INTESTINAL OPERATION].
    Showa Igakkai zasshi = The Journal of the Showa Medical Association, 1964, Volume: 24

    Topics: Animals; Chondroitin; Dogs; Drug Therapy; Intestinal Diseases; Intestinal Obstruction; Laparotomy; Postoperative Complications; Povidone; Rabbits; Research; Silicon; Tissue Adhesions

1964
chemdatabank.com